Observational study investigating patients with paraneoplastic myeloneuropathy and underlying cancer

Takeaway

  • Recognition of the key characteristics of paraneoplastic myeloneuropathy may help facilitate earlier tumor diagnosis and guide treatment decisions.

Why this matters

  • Myelopathy and neuropathy manifestations in paraneoplastic syndromes have been associated with breast and lung cancers, but the concomitant development of these manifestations have not been well studied.

  • The results from this study may help with earlier recognition of the differentiating characteristics of paraneoplastic myeloneuropathies that can help clinical diagnosis and management.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.